SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 02.11.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis buy | HSBC | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.10.17 | Novartis buy | Baader Bank | |
| 30.10.17 | Novartis Neutral | UBS AG | |
| 30.10.17 | Novartis buy | HSBC | |
| 30.10.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.10.17 | Novartis Outperform | Bernstein Research | |
| 25.10.17 | Novartis Underweight | Barclays Capital | |
| 25.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 25.10.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 25.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.10.17 | Novartis Hold | S&P Capital IQ | |
| 24.10.17 | Novartis buy | Baader Bank | |
| 24.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.10.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.10.17 | Roche Neutral | UBS AG | |
| 23.10.17 | Novartis Neutral | UBS AG | |
| 20.10.17 | Roche Equal-Weight | Morgan Stanley | |
| 20.10.17 | Novartis overweight | Morgan Stanley | |
| 20.10.17 | Roche Hold | Deutsche Bank AG | |
| 20.10.17 | Roche Hold | Kepler Cheuvreux | |
| 20.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.10.17 | Roche Reduce | HSBC | |
| 19.10.17 | Roche Neutral | UBS AG | |
| 19.10.17 | Roche Hold | Baader Bank | |
| 19.10.17 | Roche overweight | JP Morgan Chase & Co. | |
| 18.10.17 | Roche Neutral | Citigroup Corp. | |
| 17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.10.17 | Roche overweight | JP Morgan Chase & Co. | |
| 16.10.17 | Roche buy | Jefferies & Company Inc. | |
| 16.10.17 | Novartis buy | Jefferies & Company Inc. | |
| 16.10.17 | Roche Neutral | Credit Suisse Group | |
| 12.10.17 | Novartis buy | HSBC | |
| 12.10.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 10.10.17 | Novartis Neutral | JP Morgan Chase & Co. |